Centro de Investigación del Cáncer
In research, Centro de Investigación del Cáncer stands highest in Medicine (#5,969 of 10,443 worldwide) and Health Sciences (#7,211 of 11,982 worldwide), 2022–2025.
- World rank, 2022–2025
- #8,395 of 28,054 · #7,512 all time
- Rank in Spain
- #223 of 658
- Research works
- 938 ◆ 0% vs 2013–17
- Citations
- 45k 47.9 per fractional work
- Top-10% rate
- 24.8% record average 16.5%
- Open access
- 56% world 28%
What is Centro de Investigación del Cáncer known for in research?
The fields where it stands highest, 2022–2025, ranked among every institution above the floor in each field.
| Field | World rank | Where that sits | Top-10% rate | Works | All time |
|---|---|---|---|---|---|
| MedicineField | #5,969 of 10,443 | 25.1% | 78 | #4343 | |
| Health SciencesDomain | #7,211 of 11,982 | 25.0% | 79 | #5837 |
Each strip is that field’s whole ranked pool, with the notch where Centro de Investigación del Cáncer sits in it, in the colour of the band that rank falls in. The track under the rate is the rate itself: it carries no world mark, because the world rate differs by field (from about 6% to 21% in this record).
Field profile
Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.
Rings at 0.5×, 1× and 2×. Widest outward: Immunology and Microbiology, 7.2×. Every wedge is a field page.
- Immunology and Microbiology 7.2×
- Biochemistry, Genetics and Molecular Biology 5.6×
- Medicine 2.8×
- Pharmacology, Toxicology and Pharmaceutics 0.6×
- Chemistry 0.6×
- Neuroscience 0.4×
- Nursing 0.3×
- Veterinary 0.3×
- Energy 0.2×
- Dentistry 0.2×
- Decision Sciences 0.2×
- Agricultural and Biological Sciences 0.2×
- Materials Science 0.2×
- Physics and Astronomy 0.2×
- Computer Science 0.1×
- Environmental Science 0.1×
- Engineering 0.1×
- Health Professions 0.1×
- Economics, Econometrics and Finance 0.1×
- Psychology 0.0×
- Arts and Humanities 0.0×
- Social Sciences 0.0×
- Mathematics 0.0×
Who are the top researchers at Centro de Investigación del Cáncer?
Ranked on the composite score, Norma C. Gutiérrez, Xosé R. Bustelo and Juan Luis Garcı́a lead among researchers whose main affiliation is Centro de Investigación del Cáncer.
- 1 Norma C. Gutiérrez Spain · #86,636 worldwide 190 citations · 51 works
- 2 Xosé R. Bustelo Spain · #211,440 worldwide 176 citations · 28 works
- 3 Juan Luis Garcı́a Spain · #294,387 worldwide 98 citations · 35 works
- 4 Atanasio Pandiella Spain · #470,396 worldwide 204 citations · 68 works
- 5 María-Victoria Mateos Spain · #632,652 worldwide 54 citations · 17 works
- 6 Javier De Las Rivas Spain · #682,039 worldwide 75 citations · 42 works
- 7 María Abáigar Spain · #903,211 worldwide 11 citations · 16 works
- 8 Eva Lumbreras Spain · #1,112,177 worldwide 15 citations · 15 works
- 9 Rocío Benito Spain · #1,126,241 worldwide 14 citations · 18 works
Which keywords describe research at Centro de Investigación del Cáncer?
By fractional works in 2022–2025, weighted toward what it does more of than the world: Prognostic Factors, Cancer, Minimal Residual Disease, Proteasome Inhibitors, Cancer Therapy, Immunotherapy, Staging System and Diagnosis Criteria.
- Molecular Profiling
- Glycosylation
- Gene Expression Profiling
- Mutation
- Genomic Instability
- Genetic Mutations
- Chimeric Antigen Receptor
- Acute Myeloid Leukemia
- Leukemia
- Targeted Therapy
- Chronic Lymphocytic Leukemia
- Chemotherapy
- Cancer Immunotherapy
- Hematopoietic Stem Cells
- Lymphoma
- Inflammation
- Diagnosis Criteria
- Immunotherapy
- Proteasome Inhibitors
- Cancer
- Prognostic Factors
- Minimal Residual Disease
- Cancer Therapy
- Staging System
- International Myeloma Working Group
- Rituximab
- Transcriptional Regulation
- Tumor Microenvironment
- Therapeutic Targets
- PET Imaging
- Genomic Aberrations
- Tumor Regression
- AML
- CAR T Cells
- Gene Expression
- Angiogenesis
- BET Bromodomains
- PROTACs
- Genetic Alterations
- Immunosuppression
Size is fractional works in 2022–2025 in the topics tagged with each word; colour is the word's share of this institution's work against its share of the world's. The 40 words are chosen for being large and distinctive. Each links to the topic it comes from most.
All 40 words, with their numbers
- Prognostic Factors13▲ 21×12 topics
- Cancer13▲ 6.5×41 topics
- Minimal Residual Disease12▲ 114×2 topics
- Proteasome Inhibitors11▲ 108×2 topics
- Cancer Therapy10▲ 12×13 topics
- Immunotherapy10▲ 9.6×17 topics
- Staging System10▲ 107×2 topics
- Diagnosis Criteria9▲ 176×1 topic
- International Myeloma Working Group9▲ 176×1 topic
- Inflammation9▲ 2.8×44 topics
- Rituximab8▲ 36×3 topics
- Lymphoma7▲ 30×3 topics
- Transcriptional Regulation6▲ 26×7 topics
- Hematopoietic Stem Cells6▲ 47×3 topics
- Tumor Microenvironment6▲ 9.3×8 topics
- Cancer Immunotherapy6▲ 25×3 topics
- Therapeutic Targets6▲ 25×7 topics
- Chemotherapy5▲ 5.3×18 topics
- PET Imaging5▲ 22×4 topics
- Chronic Lymphocytic Leukemia5▲ 75×1 topic
- Genomic Aberrations5▲ 75×1 topic
- Targeted Therapy5▲ 15×5 topics
- Tumor Regression4▲ 27×2 topics
- Leukemia4▲ 35×2 topics
- AML4▲ 58×1 topic
- Acute Myeloid Leukemia4▲ 58×1 topic
- CAR T Cells4▲ 37×1 topic
- Chimeric Antigen Receptor4▲ 37×1 topic
- Gene Expression4▲ 4.5×12 topics
- Genetic Mutations4▲ 6.0×12 topics
- Angiogenesis4▲ 7.7×9 topics
- Genomic Instability4▲ 22×3 topics
- BET Bromodomains3▲ 82×1 topic
- Mutation3▲ 12×5 topics
- PROTACs3▲ 82×1 topic
- Gene Expression Profiling3▲ 26×2 topics
- Genetic Alterations3▲ 28×2 topics
- Glycosylation3▲ 19×3 topics
- Immunosuppression3▲ 24×3 topics
- Molecular Profiling3▲ 21×3 topics
Which research topics does Centro de Investigación del Cáncer publish most on?
By volume in 2022–2025: Multiple Myeloma Research and Treatments, Chronic Lymphocytic Leukemia Research, Acute Myeloid Leukemia Research and CAR-T cell therapy research.
Area is fractional works; colour is the subfield each topic belongs to.
- 1 Multiple Myeloma Research and Treatments Hematology 9 works
- 2 Chronic Lymphocytic Leukemia Research Genetics 5 works
- 3 Acute Myeloid Leukemia Research Hematology 4 works
- 4 CAR-T cell therapy research Oncology 4 works
- 5 Protein Degradation and Inhibitors Molecular Biology 3 works
- 6 Lymphoma Diagnosis and Treatment Pathology and Forensic Medicine 3 works
- 7 Acute Lymphoblastic Leukemia research Public Health, Environmental and Occupational Health 2 works
- 8 Monoclonal and Polyclonal Antibodies Research Radiology, Nuclear Medicine and Imaging 2 works
- 9 Ubiquitin and proteasome pathways Molecular Biology 2 works
- 10 Cancer Genomics and Diagnostics Cancer Research 2 works
How open and international is its research?
Against the world’s own shares — the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.
World: 28% of research is openly available.
World: 19% is written across borders.
How has Centro de Investigación del Cáncer's research output changed?
Output in 2018–2022 was 0% higher than in 2013–2017.
The same series as a ribbon — one cell per year, darker for more. The line above answers how much; this answers when.
Other research institutions in Salamanca
- Universidad de Salamanca
- Complejo Hospitalario de Salamanca
- Universidad Pontificia de Salamanca
- Instituto de Investigación Biomédica de Salamanca
- Instituto de Recursos Naturales y Agrobiología de Salamanca
- Asociación Universitaria Iberoamericana de Postgrado
- Red Temática de Investigación Cooperativa en Cáncer
- Itelsa (Spain)
Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners are in the interactive view on the map.